Topical Composition for Joint Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammatory and autoimmune-related conditions, such as osteoarthritis, lack effective topical solutions that can provide localized antioxidant and anti-inflammatory effects while minimizing systemic impact.
Innovation Solution
A topical composition combining L-carnosine and chondroitin sulfate, potentially with additional ingredients like magnesium sulfate, phenoxyethanol, tetrasodium glutamate diacetate, and hydroxyethyl cellulose, formulated as a gel or cream to provide synergistic antioxidant and anti-inflammatory effects directly on affected joints.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic treatments are used for inflammatory and autoimmune conditions, then anti-inflammatory effects are achieved, but systemic side effects increase
Solution Approach 1:
The patent applies local quality by formulating a topical composition that delivers antioxidant and anti-inflammatory agents directly to the affected joint area. The composition includes L-carnosine, chondroitin sulfate, and other ingredients that provide localized treatment, ensuring the therapeutic effect is concentrated where needed while minimizing exposure to the rest of the body, thus reducing systemic side effects.
2Object-affected harmful factors
If topical compositions are applied to joints, then localized treatment is provided, but penetration depth and effectiveness are limited
Solution Approach 1:
The patent employs composite materials by combining multiple active ingredients (L-carnosine, chondroitin sulfate, magnesium sulfate, phenoxyethanol, tetrasodium glutamate diacetate, and hydroxyethyl cellulose) in a topical formulation. This composite approach enhances the overall effectiveness of the treatment by leveraging the synergistic effects of each component, improving penetration and therapeutic impact while maintaining localized application.
3Reliability
If multiple ingredients are combined in topical composition, then synergistic effects are achieved, but formulation complexity increases
Solution Approach 1:
The patent applies universality by designing a multi-functional topical composition where each ingredient serves multiple purposes. For example, L-carnosine provides antioxidant activity and anti-inflammatory effects, while chondroitin sulfate contributes to joint health and inflammation reduction. This multi-functionality approach achieves synergistic effects without proportionally increasing formulation complexity, as each component contributes to multiple therapeutic goals.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces inflammation and oxidative stress in joints by neutralizing reactive oxygen species and modulating NF-κB activation, offering a localized treatment for inflammatory and autoimmune diseases with potential systemic benefits.
Implementation Method 1
Antioxidant capacity; scavenges reactive oxygen species (ROS).
Implementation Method 2
The effect of chondroitin sulfate in people with osteoarthritis is likely the result of a number of reactions including its anti-inflammatory activity
Implementation Method 3
A topical composition combining L-carnosine and chondroitin sulfate, potentially with additional ingredients like magnesium sulfate, phenoxyethanol, tetrasodium glutamate diacetate, and hydroxyethyl cellulose, formulated as a gel or cream to provide synergistic antioxidant and anti-inflammatory effects directly on affected joints.
Data Source
AI summary
Provided herein are pharmaceutical compositions, such as topical compositions, comprising carnosine and chondroitin sulfate. Also provided herein are methods of preparing the pharmaceutical compositions and methods of using the same for treating inflammation and diseases associated with inflammation and/or autoimmune reactions.